新闻动态
Enzolifesciences/TIRAP (human) monoclonal antibody (Sebi-1)/ALX-804-829-C100/100µg
2025-11-16
Product Specification:
| Alternative Name: | Toll-interleukin 1 receptor domain-containing adapter protein, MyD88 adapter-like protein, Mal |
| Clone: | Sebi-1 |
| Host: | Rat |
| Isotype: | IgG2a |
| Immunogen: | Recombinant human TIRAP(Mal) (aa 1-215). |
| UniProt ID: | P58753 |
| Species reactivity: | Human |
| Applications: | IP, WB |
| Recommended Dilutions/Conditions: | Immunoprecipitation (1:200)Western Blot (1:500)Suggested dilutions/conditions may not be available for all applications.Optimal conditions must be determined individually for each application. |
| Formulation: | Liquid. In PBS containing 0.02% sodium azide. |
| Use/Stability: | Stable for at least 1 year after receipt when stored at -20°C. |
| Handling: | Avoid freeze/thaw cycles. |
| Shipping: | Shipped on Blue Ice |
| Short Term Storage: | +4°C |
| Long Term Storage: | -20°C |
| Scientific Background: | Toll-like receptors (TLRs) play an essential role in the detection and elimination of invading pathogens. Recognition of microbial components by TLRs triggers activation of the innate immune system. Upon stimulation, these receptors interact with specific TIR domain-containing adaptor proteins. Five such adaptors have been discovered to date, MyD88, Trif (TIR-domain-containing adaptor inducing interferon-β), TIRAP (TIR domain-containing adaptor protein)/Mal (MyD88 adaptor-like), TRAM (Trif-related adaptor molecule) and SARM (SAM and ARM-containing protein). MyD88 is common to all TLR-mediated pathways, which lead to the production of inflammatory cytokines, whereas TRIF mediates induction of IFN-β in TLR3 and TLR4 signalling pathways. TIRAP/Mal is implicated in the TLR2- and TLR4-mediated MyD88-dependent signalling pathway. TRAM is specifically involved in the TLR4-mediated TRIF-dependent pathway. Thus, TIR domain-containing adaptors provide specificity of TLR signalling. |
本文链接： https://www.ebiomall.cn/b6-echelon/info-1519626284.html
免责声明 本文仅代表作者个人观点，与本网无关。其创作性以及文中陈述文字和内容未经本站证实，对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺，请读者仅作参考，并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的，应该授权范围内使用，并注明“来源：蚂蚁淘”。违反上述声明者，本网将追究其相关法律责任。
相关文章
2020-06-21
2020-06-29
2020-07-08
2020-07-20
2020-09-13
2020-09-15
2020-10-02
2020-10-24
2020-11-12
2021-03-16
▍
官网分类
▍
品牌问答
